WallStSmart
IBO

Impact BioMedical, Inc.

AMEX: IBO · HEALTHCARE · BIOTECHNOLOGY

$0.66
-2.59% today

Updated 2026-05-01

Market cap
$71.16M
P/E ratio
P/S ratio
2,223.81x
EPS (TTM)
$-0.38
Dividend yield
52W range
$0 – $2
Volume
5.4M

WallStSmart proprietary scores

15
out of 100
Grade: F
Strong Sell
Investment rating
3.3
Growth
D
4.5
Quality
C
2.5
Profitability
F
5.0
Valuation
C+
3/9
Piotroski F-Score
Weak
-3.4
Altman Z-Score
Distress
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
$—
12-Month target
Intrinsic (DCF)
Margin of safety

Price chart

X-Ray snapshot

Strengths
+ Free cash flow $99000.00 — positive
+ Debt/equity -1.94x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -3.39 — distress zone
- Thin margins at 0.00%

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$50000.00$1.03M$2.33M$32000.00$32000.00
Net income$-7.05M$-4.34M$-2.05M$-11.84M$5.25M
EPS$-0.38
Free cash flow$-4.43M$-2.87M$-5.64M$-1.89M$99000.00
Profit margin-14,102.00%-420.98%-88.01%-36,993.75%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
IBO$71.16M153.32.55.04.5Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-26.29%Buy
UNH$336.47B545.35.57.34.8+42.09%Buy
AZN$287.11B646.78.05.35.0+4.07%Buy

Smart narrative

Impact BioMedical, Inc. trades at $0.66. Our Smart Value Score of 15/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -3.39, it sits in the distress. TTM revenue stands at $32000.00.

Frequently asked questions

What is Impact BioMedical, Inc.'s stock price?
Impact BioMedical, Inc. (IBO) trades at $0.66.
Is Impact BioMedical, Inc. overvalued?
Smart Value Score 15/100 (Grade F, Strong Sell).
What is the price target of Impact BioMedical, Inc. (IBO)?
The analyst target price is $—, representing NaN% downside from the current price of $0.66.
What is Impact BioMedical, Inc.'s revenue?
TTM revenue is $32000.00.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
-3.39 — distress.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeAMEX
CurrencyUSD

Quick metrics

P/S ratio2,223.81x
ROE-104.20%
Beta
50D MA$0.57
200D MA$0.56
Shares out0.11B
Float0.01B
Short ratio
Avg volume5.4M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years